×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
16827 views

Modératrice : Dr Lauriane Eberst (ICANS Strasbourg)

 

18:00
Les nouvelles thérapies ciblées et les nouveaux standards dans le cancer du sein métastatique HER2+
Dr Isabelle Desmoulins (CGFL Dijon)
 
 
18:30
Approche pratique autour d’un cas clinique
Dr Christelle Jouannaud (CLCC Reims)
  
Shooting date : 2021-10-14
Last update : 2021-10-15

Suggestions

Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Honolulu : Thursday, March 10th 2022 from 08am to 10am (GMT+1)
San Francisco : Thursday, March 10th 2022 from 10am to 12pm (GMT+1)
New York : Thursday, March 10th 2022 from 01pm to 03pm (GMT+1)
Buenos Aires : Thursday, March 10th 2022 from 03pm to 05pm (GMT+1)
London / Dublin : Thursday, March 10th 2022 from 06pm to 08pm (GMT+1)
Paris / Berlin : Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Istanbul : Thursday, March 10th 2022 from 08pm to 10pm (GMT+1)
Moscou / Dubaï : Thursday, March 10th 2022 from 10pm to 12am (GMT+1)
Bangkok : Friday, March 11th 2022 from 01am to 03am (GMT+1)
Shanghai : Friday, March 11th 2022 from 02am to 04am (GMT+1)
Tokyo : Friday, March 11th 2022 from 03am to 05am (GMT+1)
Sydney : Friday, March 11th 2022 from 04am to 06am (GMT+1)
Wellington : Friday, March 11th 2022 from 06am to 08am (GMT+1)

Changement de paradigme dans les cancers du sein triple négatif métastatique - de la théorie à l...

Share
Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT+2)
New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+2)
Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+2)
Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Honolulu : Tuesday, March 28th 2023 from 08am to 09:30am (GMT+2)
San Francisco : Tuesday, March 28th 2023 from 11am to 12:30pm (GMT+2)
New York : Tuesday, March 28th 2023 from 02pm to 03:30pm (GMT+2)
Buenos Aires : Tuesday, March 28th 2023 from 03pm to 04:30pm (GMT+2)
Reykjavik : Tuesday, March 28th 2023 from 06pm to 07:30pm (GMT+2)
London / Dublin : Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Paris / Berlin : Tuesday, March 28th 2023 from 08pm to 09:30pm (GMT+2)
Istanbul : Tuesday, March 28th 2023 from 09pm to 10:30pm (GMT+2)
Moscou / Dubaï : Tuesday, March 28th 2023 from 10pm to 11:30pm (GMT+2)
Bangkok : Wednesday, March 29th 2023 from 01am to 02:30am (GMT+2)
Shanghai : Wednesday, March 29th 2023 from 02am to 03:30am (GMT+2)
Tokyo : Wednesday, March 29th 2023 from 03am to 04:30am (GMT+2)
Sydney : Wednesday, March 29th 2023 from 05am to 06:30am (GMT+2)
Wellington : Wednesday, March 29th 2023 from 07am to 08:30am (GMT+2)

La prise en charge des cancers du sein triple négatifs :

intégration des innovations thérapeutiques dans les algorithmes et gestion des effets secondaires

Share
Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, January 18th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Thursday, January 18th 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, January 18th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, January 18th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, January 18th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, January 18th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, January 18th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, January 19th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, January 19th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, January 19th 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, January 19th 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, January 19th 2024 from 05am to 06:30am (GMT+1)

Cancer du sein triple négatif métastatique

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up